251 related articles for article (PubMed ID: 12954220)
1. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.
Mealey RH; Zhang B; Leib SR; Littke MH; McGuire TC
Virology; 2003 Sep; 313(2):537-52. PubMed ID: 12954220
[TBL] [Abstract][Full Text] [Related]
2. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
Zhang W; Lonning SM; McGuire TC
J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
[TBL] [Abstract][Full Text] [Related]
3. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses.
Chung C; Mealey RH; McGuire TC
Virology; 2005 Nov; 342(2):228-39. PubMed ID: 16139857
[TBL] [Abstract][Full Text] [Related]
5. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
[TBL] [Abstract][Full Text] [Related]
6. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779
[TBL] [Abstract][Full Text] [Related]
7. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
Howe L; Leroux C; Issel CJ; Montelaro RC
J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
[TBL] [Abstract][Full Text] [Related]
8. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
Zhang W; Auyong DB; Oaks JL; McGuire TC
Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.
Fraser DG; Leib SR; Zhang BS; Mealey RH; Brown WC; McGuire TC
Clin Diagn Lab Immunol; 2005 Aug; 12(8):983-93. PubMed ID: 16085917
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
McGuire TC; Fraser DG; Mealey RH
Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
[TBL] [Abstract][Full Text] [Related]
11. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.
Lonning SM; Zhang W; Leib SR; McGuire TC
J Virol; 1999 Apr; 73(4):2762-9. PubMed ID: 10074123
[TBL] [Abstract][Full Text] [Related]
12. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.
Ridgely SL; McGuire TC
Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769
[TBL] [Abstract][Full Text] [Related]
13. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
Mealey RH; Leib SR; Pownder SL; McGuire TC
J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
[TBL] [Abstract][Full Text] [Related]
14. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
Leroux C; Craigo JK; Issel CJ; Montelaro RC
J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
[TBL] [Abstract][Full Text] [Related]
15. Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge.
Ridgely SL; Zhang B; McGuire TC
Vaccine; 2003 Jan; 21(5-6):491-506. PubMed ID: 12531649
[TBL] [Abstract][Full Text] [Related]
16. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
[TBL] [Abstract][Full Text] [Related]
17. CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.
Chung C; Mealey RH; McGuire TC
Virology; 2004 Sep; 327(1):144-54. PubMed ID: 15327905
[TBL] [Abstract][Full Text] [Related]
18. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.
Hammond SA; Cook SJ; Lichtenstein DL; Issel CJ; Montelaro RC
J Virol; 1997 May; 71(5):3840-52. PubMed ID: 9094660
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.
Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC
J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657
[TBL] [Abstract][Full Text] [Related]
20. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses.
McGuire TC; Leib SR; Lonning SM; Zhang W; Byrne KM; Mealey RH
J Gen Virol; 2000 Nov; 81(Pt 11):2735-2739. PubMed ID: 11038386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
